(Q52954955)

English

The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment.

scientific article published in October 2002

  • The impact of the polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment

Statements

The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit